Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07444099

Early Postoperative Intervention in Gastric Cancer Patients

This study was conducted by Qilu Hospital and five other renowned medical centers, aiming to evaluate the impact of early structured postoperative intervention on quality of life and prognosis in patients with gastric cancer after neoadjuvant therapy.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Qilu Hospital of Shandong University

Jinan, Shandong, 250012, China

About this study

Investigators are conducting a two-arm, multicenter, interventional study at Qilu Hospital of Shandong University and five other renowned hospitals in China. A total of 264 gastric cancer patients who have completed preoperative neoadjuvant therapy will be randomly assigned to either the control group or the experimental group.For control group,patients will receive standard ERAS discharge management, including routine discharge education; outpatient follow-up visits on postoperative day 7 and postoperative day 30; and emergency contact via hospital telephone or emergency department visits for urgent situations.For experimental group,in addition to standard ERAS discharge management, patients will receive multimodal structured interventions during follow-up visits targeting nutritional status, psychological status, and exercise status. Nutritional intervention: Routine postoperative oral nutritional supplements (ONS) will be provided, and patients with metabolic diseases such as diabetes will undergo strict glycemic control. Psychological intervention: Patients with a Hospital Anxiety and Depression Scale (HADS) score ≥ 8 will receive cognitive behavioral therapy (CBT), and those with a HADS score ≥ 11 will be referred for psychological consultation. Exercise intervention: Postoperative rehabilitation training will be guided according to different postoperative periods.During the study period, the incidence of complications within 30 days postoperatively and quality of postoperative recovery were statistically analyzed, among other outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-80 years;
  • Histologically confirmed adenocarcinoma by preoperative pathology;
  • Completed preoperative neoadjuvant therapy without obvious immune-related adverse events (irAEs);
  • Patients with ycT3-4N+Mx disease deemed surgically resectable based on evaluation by gastroscopy, CT, PET-CT, and other imaging modalities;
  • Signed informed consent and voluntary participation in this study;
  • Standard ERAS (Enhanced Recovery After Surgery) management during the - perioperative period, with postoperative hospital stay ≤7 days.

Exclusion criteria

  • Patients with central nervous system diseases or psychiatric disorders;
  • Patients with severe diseases of other organ systems;
  • Patients with recurrent infectious diseases or severe comorbidities;
  • Patients requiring synchronous surgery for other diseases;
  • Patients undergoing emergency surgery;
  • Patients who developed any complication during hospitalization.

Treatment and study plan

Early structured postoperative intervention encompassing nutrition, psychology, and exercise

Combination Product

Nutritional intervention: Routine postoperative oral nutritional supplements (ONS) will be provided, and patients with metabolic diseases such as diabetes will undergo strict glycemic control. Psychological intervention: Patients with a Hospital Anxiety and Depression Scale (HADS) score ≥ 8 will receive cognitive behavioral therapy (CBT), and those with a HADS score ≥ 11 will be referred for psychological consultation. Exercise intervention: Postoperative rehabilitation training will be guided according to different postoperative periods.

Primary outcomes

  1. incidence of complications within 30 days postoperatively

    Time frame: 30 days after operation

    The incidence of complications within 30 days postoperatively was calculated as the number of patients who developed complications within 30 days after surgery divided by the total number of patients in that group.

  2. Postoperative recovery quality

    Time frame: Baseline (Day of Discharge) and POD 30(30 days after surgery)

    Postoperative recovery quality was assessed using The 15-item Quality of Recovery Score scale, with a maximum score of 150 points and a minimum score of 0 points, where higher scores indicate better postoperative recovery quality

Secondary outcomes

  1. Readmission or emergency department visit rate within 30 days postoperatively

    Time frame: 30 days after surgery

    The rate of Readmission or emergency department visit within 30 days postoperatively was calculated as the number of patients who was readmitted or visited emergency department within 30 days after surgery divided by the total number of patients in that group.

  2. Time interval between surgery and initiation of adjuvant chemotherapy

    Time frame: 6 month after surgery

    The time interval was calculated as the number of days from postoperative day 1 to the start of adjuvant chemotherapy.

  3. Completion rate of postoperative chemotherapy / Adherence to adjuvant chemotherapy

    Time frame: 6 month after surgery

    The completion rate of postoperative chemotherapy was calculated as the number of chemotherapy cycles actually completed divided by the number of chemotherapy cycles planned.

  4. Grading of chemotherapy-related adverse events

    Time frame: 6 month after surgery

    It was evaluated by CTCAE version 5.0,with severity classified from Grade 1 (mild) to Grade 5 (death).

  5. Postoperative quality of life score

    Time frame: Baseline (Day of Discharge) and POD 30(30 days after surgery)

    The EORTC Quality of Life Questionnaire for Gastric Cancer (C30 + STO22) questionaire was used to evaluate quality of postoperative recovery, all scales range from 0 to 100. For global health status, higher scores indicate better outcomes; for all functioning and symptom scales in both questionnaires, higher scores indicate worse outcomes.

Sponsors and collaborators

Lead sponsor

Qilu Hospital of Shandong University

Other

Collaborators

  • Central Hospital of Zibo
  • Liaocheng People's Hospital
  • Linyi People's Hospital
  • Weifang People's Hospital
  • Yantai Yuhuangding Hospital

Registry information

Official study title

Early Postoperative Structured Intervention for Quality of Life and Prognosis in Gastric Cancer Patients After Neoadjuvant Therapy:: A Multicenter,Open Label Randomized Controlled Trial

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 2, 2026
Registry last updated
Mar 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.